• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Daxor Corporation - Closed End Fund (NQ:DXR)

    11.52 +0.04 (+0.30%)
    Streaming Delayed Price Updated: 11:19 AM EDT, Mar 16, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Daxor Corporation - Closed End Fund

    News headline image
    Updated Lineup Announced for the iAccess Alpha Virtual Best Ideas Spring Investment Conference March 10-11, 2026
    Via ACCESS Newswire
    News headline image
    Daxor Corporation Announces Closing of $2.1 million Underwritten Public Offering and Exercise of Over-Allotment Option
    From Daxor Corporation
    Via GlobeNewswire
    News headline image
    Daxor Corporation Announces Pricing of $2.0 million Underwritten Public Offering
    From Daxor Corporation
    Via GlobeNewswire
    News headline image
    Daxor Corporation Announces Launch of Proposed Underwritten Public Offering
    From Daxor Corporation
    Via GlobeNewswire
    News headline image
    Live Webinar by MedAxiom Features Best Practices Using Daxor’s Blood Volume Analysis (BVA-100®) to Improve Heart Failure Outcomes and Reduce Costs
    From Daxor Corporation
    Via GlobeNewswire
    News headline image
    Newly Published Study Demonstrates Significant Clinical Utility of Daxor’s Blood Volume (BVA-100®) Diagnostic in the Evaluation of Heart Failure
    From Daxor Corporation
    Via GlobeNewswire
    News headline image
    Daxor Corporation to Exhibit at American Heart Association’s Scientific Sessions 2022
    From Daxor Corporation
    Via GlobeNewswire
    News headline image
    Expert Panel Calls for Use of Blood Volume Measurement to Assess Heart Failure Patients at Key Scientific Meeting
    From Daxor Corporation
    Via GlobeNewswire
    News headline image
    DAXOR CORPORATION TO EXHIBIT AND PRESENT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE FALL’22 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR’S BLOOD VOLUME DIAGNOSTIC (BVA-100®)
    From Daxor Corporation
    Via GlobeNewswire
    News headline image
    Study Data from Mayo Clinic on Heart Failure Treatment Effectiveness Utilizing Daxor BVA-100 Presented at Key Scientific Meeting
    From Daxor Corporation
    Via GlobeNewswire
    News headline image
    New Data Shows Heart Failure Treatment Guided by Daxor’s BVA-100® Lowers Hospital Length of Stay by 55%
    From Daxor Corporation
    Via GlobeNewswire
    News headline image
    New Data Shows 85% Reduction In One-Year Mortality For Medicare Heart Failure Patients With BVA-Guided Care
    From Daxor Corporation
    Via GlobeNewswire
    News headline image
    New Studies Validating the Uniqueness of the BVA-100® Blood Test for Heart Failure Patients Compared to Pressure Measures
    From Daxor Corporation
    Via GlobeNewswire
    News headline image
    Daxor Corporation Announces a 49.4% Increase In Its Single-Use Diagnostic Kits Year-Over-Year and Further Acquisitions of its BVA-100® Blood Volume Analyzer by Leading Medical Centers Throughout the U.S.
    From Daxor Corporation
    Via GlobeNewswire
    News headline image
    35 of the Best Ideas Companies to Present at the Summer Solstice - Best Ideas from the Buy-Side Virtual Investor Conference on June 1-4, 2021
    RALEIGH, NC / ACCESSWIRE / May 27, 2021 / The Summer Solstice - Best Ideas from the Buy-Side will take place on June 1-4, 2021, where 35 SmallCap, MicroCap and NanoCap public companies will be... 
    From MicroCap Rodeo
    Via AccessWire
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.